Introduction to Entry
Introduction to Entry
Foshan Hanteng Biotechnology Co., LTD
Hanteng Bio was established in Shunde District, Foshan City in 2016. It is a high-tech biomedical enterprise that has grown up with advantageous industrial resources at home and abroad. The core business is biomedical contract R&D and production service (CDMO), which is the first biopharmaceutical CDMO enterprise in South China, filling the gap in biopharmaceutical R&D and production service industry in Guangdong-Hong Kong-Macao Greater Bay Area, and has provided development and production services for biological macromolecular drugs such as monoclonal antibody, double antibody, fusion protein and recombinant protein for many domestic and foreign biopharmaceutical enterprise customers.
Tiqi Pharmaceutical (Foshan) Co., LTD
Digi Pharma is a pharmaceutical high-tech enterprise focusing on innovative and improved formulations (microspheres, implants, in-situ gels, targeted nano, slow release formulations, etc.), biodegradable excipients, and related technologies and products industrialization.
Dci Pharmaceutical completed the registration and filing of six high-end excipients in China and the United States that comply with cGMP, filling the domestic gap and solving the key technologies and excipients that are jammed in long-acting preparations; Established a high-end formulation technology platform with independent intellectual property protection, developed a rich pipeline of high-end formulation products, and obtained the Sino-American clinical license of the world's first "risperidone microsphere for injection" every four weeks, the U.S. clinical license of a Class 2 innovative drug, and the MAH drug production license.
Guangdong Weitong Lihua Experimental Animal Technology Co., LTD
Vitonlihua is committed to providing researchers with access to high-quality animal models and innovative services, and has been engaged in the field of laboratory animals for more than 20 years. It has become a diversified service platform covering animal model preparation, animal experiments, animal testing, human cell material supply, Cradl New drug acceleration laboratory, etc.
At present, Vitonlihua has established a number of production and service facilities in China following the unified advanced management concept of Charles RiverLaboratories, respectively in Beijing, Shanghai, Zhejiang Pinghu, Zhejiang Tongxiang, Guangdong Shunde, Hubei Wuhan, Sichuan Chengdu and other regions. These facilities strictly follow the standardized biosafety management system, IGS genetic management system, VAF/SPF health management system, and continue to provide high-quality animal models and related services for researchers.
At Charles River|, we strive to innovate and collaborate with Chinese researchers to improve health and quality of life for everyone around the world.
Guangdong true Red Biotechnology Co., LTD
True Red Biology is a company focusing on modern solid-state fermentation of new Chinese medicine, modern liquid fermentation of new Chinese medicine, committed to providing quality products and services for people's health and better life. As a company based on innovative and entrepreneurial scientific and technological achievements and the core technology of modern fermentation raw medicine, true Red Biotechnology has excellent strains, patented equipment, fungal metabolites and biosynthesis patents and proprietary technology, making products safer, more effective and stable.
In the future, True Red Biology will further develop modern Chinese medicine preparation and related technologies by creating a large health industry ecology, and make more contributions to the development of human health.
Foshan Hanteng Biotechnology Co., LTD
Hanteng Bio was established in Shunde District, Foshan City in 2016. It is a high-tech biomedical enterprise that has grown up with advantageous industrial resources at home and abroad. The core business is biomedical contract R&D and production service (CDMO), which is the first biopharmaceutical CDMO enterprise in South China, filling the gap in biopharmaceutical R&D and production service industry in Guangdong-Hong Kong-Macao Greater Bay Area, and has provided development and production services for biological macromolecular drugs such as monoclonal antibody, double antibody, fusion protein and recombinant protein for many domestic and foreign biopharmaceutical enterprise customers.
Tiqi Pharmaceutical (Foshan) Co., LTD
Digi Pharma is a pharmaceutical high-tech enterprise focusing on innovative and improved formulations (microspheres, implants, in-situ gels, targeted nano, slow release formulations, etc.), biodegradable excipients, and related technologies and products industrialization.
Dci Pharmaceutical completed the registration and filing of six high-end excipients in China and the United States that comply with cGMP, filling the domestic gap and solving the key technologies and excipients that are jammed in long-acting preparations; Established a high-end formulation technology platform with independent intellectual property protection, developed a rich pipeline of high-end formulation products, and obtained the Sino-American clinical license of the world's first "risperidone microsphere for injection" every four weeks, the U.S. clinical license of a Class 2 innovative drug, and the MAH drug production license.
Guangdong Weitong Lihua Experimental Animal Technology Co., LTD
Vitonlihua is committed to providing researchers with access to high-quality animal models and innovative services, and has been engaged in the field of laboratory animals for more than 20 years. It has become a diversified service platform covering animal model preparation, animal experiments, animal testing, human cell material supply, Cradl New drug acceleration laboratory, etc.
At present, Vitonlihua has established a number of production and service facilities in China following the unified advanced management concept of Charles RiverLaboratories, respectively in Beijing, Shanghai, Zhejiang Pinghu, Zhejiang Tongxiang, Guangdong Shunde, Hubei Wuhan, Sichuan Chengdu and other regions. These facilities strictly follow the standardized biosafety management system, IGS genetic management system, VAF/SPF health management system, and continue to provide high-quality animal models and related services for researchers.
At Charles River|, we strive to innovate and collaborate with Chinese researchers to improve health and quality of life for everyone around the world.
Guangdong true Red Biotechnology Co., LTD
True Red Biology is a company focusing on modern solid-state fermentation of new Chinese medicine, modern liquid fermentation of new Chinese medicine, committed to providing quality products and services for people's health and better life. As a company based on innovative and entrepreneurial scientific and technological achievements and the core technology of modern fermentation raw medicine, true Red Biotechnology has excellent strains, patented equipment, fungal metabolites and biosynthesis patents and proprietary technology, making products safer, more effective and stable.
In the future, True Red Biology will further develop modern Chinese medicine preparation and related technologies by creating a large health industry ecology, and make more contributions to the development of human health.
Perhaps you would like to know more?
Room 1301, Building 5, Kehui Life Technology Industry Center, No. 2 Kefa Road, Lecong Town, Shunde District, Foshan City, Guangdong Province
+86-0757-28900010
Room 1301, Building 5, Kehui Life Technology Industry Center, No. 2 Kefa Road, Lecong Town, Shunde District, Foshan City, Guangdong Province
点击右上角
分享给朋友吧
Perhaps you would like to know more?
Copyright © Guangdong Kehui Biotechnology Industry Co., LTD Tel：+86-0757-28900010 E-mail：kehuichanye@163.com 备案号：
Top
